To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AHDC1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
160 supporting clones for gene AHDC1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN371147 embryonic stem cells, DMSO-treated H9 cellline .a 1 to 509 1 to 509   tiling clone,   509/510
(99 %)
4 diff
(99.3 %id)
NM_001029882.2   .a 5 to 6442 1 to 6438 exact RefSeq, AAA Possibly primed on the genome, locally A rich (15/18 A in genome downstream of last aligned base) 6438/6438
(100 %)
0 diff
(100 %id)
CN415392 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2954 to 3602 1 to 651   tiling clone,   651/651
(100 %)
5 diff
(99.3 %id)
CN415393 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2992 to 3440 1 to 449       449/449
(100 %)
2 diff
(99.6 %id)
BE409979 choriocarcinoma, placenta .a 3014 to 3725 22 to 730       709/845
(83 %)
6 diff
(99.3 %id)
BE900216 choriocarcinoma, placenta .a 3042 to 3689 1 to 648       648/648
(100 %)
12 diff
(98.2 %id)
CR740793 brain .a 3115 to 3826 1 to 712   tiling clone,   712/712
(100 %)
2 diff
(99.8 %id)
CD676013 eye, lens .a 3245 to 3823 1 to 579       579/579
(100 %)
1 diff
(99.9 %id)
BF933000 nervous_tumor .a 3414 to 3548 135 to 1     Submitted on the opposite strand 135/135
(100 %)
0 diff
(100 %id)
AK125431 brain .a 3425 to 6085 1 to 2661   tiling clone, available from FLJ,   2661/2661
(100 %)
1 diff
(100.0 %id)
DA791559 brain .a 3426 to 3972 2 to 547   capped   546/547
(99 %)
3 diff
(99.5 %id)
BQ708474 Spleen .a 3460 to 4266 1 to 826       826/957
(86 %)
29 diff
(97.0 %id)
BQ709233 Spleen .a 3460 to 4088 1 to 630       630/942
(66 %)
10 diff
(99.0 %id)
BF356151 head_neck .a 3512 to 3754 1 to 240       240/240
(100 %)
8 diff
(96.7 %id)
BQ929410 epidermoid carcinoma, cell line, lung .a 3537 to 4352 1 to 821       821/904
(90 %)
33 diff
(96.4 %id)
BU526864 epidermoid carcinoma, cell line, lung .a 3537 to 4317 1 to 792       792/924
(85 %)
18 diff
(98.1 %id)
BG982935 colon_normal .a 3539 to 3733 1 to 189       189/198
(95 %)
20 diff
(89.9 %id)
BF802216 colon_ins .a 3541 to 3825 17 to 299       283/299
(94 %)
6 diff
(98.0 %id)
BF802224 colon_ins .a 3541 to 3827 303 to 18     Submitted on the opposite strand 286/323
(88 %)
0 diff
(100 %id)
R86701 brain .a 3603 to 3786 184 to 2     Submitted on the opposite strand 183/184
(99 %)
0 diff
(100 %id)
R84600 brain .a 3625 to 3775 152 to 3   tiling clone, Submitted on the opposite strand 150/152
(98 %)
0 diff
(100 %id)
AL157655 brain .a 3681 to 4262 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
CN306202 embryonic stem cells, cell lines H1, H7, andH9 .a 3896 to 4544 1 to 650       650/650
(100 %)
2 diff
(99.7 %id)
BG946293 bladder_tumor .a 4257 to 4499 9 to 247       239/247
(96 %)
12 diff
(95.2 %id)
BQ367779 placenta_normal .a 4257 to 4499 1 to 240       240/245
(97 %)
6 diff
(97.6 %id)
CD675468 eye, lens .a 4257 to 4788 1 to 532       532/532
(100 %)
0 diff
(100 %id)
DN998478 bone marrow .a 4266 to 5039 2 to 775       774/775
(99 %)
9 diff
(98.9 %id)
BF810012 colon_ins .a 4303 to 4762 469 to 11     Submitted on the opposite strand 459/469
(97 %)
0 diff
(100 %id)
BC002677 Uterus, endometrium adenocarcinoma .a 4347 to 6064 1 to 1718   available from MGC, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1718/1718
(100 %)
0 diff
(100 %id)
BC014394 Uterus, endometrium adenocarcinoma .a 4347 to 6064 1 to 1718   available from MGC, AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1718/1718
(100 %)
0 diff
(100 %id)
BE378743 endometrium, adenocarcinoma cell line, uterus .a 4366 to 5133 1 to 767   available from MGC,   767/841
(91 %)
11 diff
(98.7 %id)
BE378177 endometrium, adenocarcinoma cell line, uterus .a 4366 to 4998 1 to 650   available from MGC,   650/675
(96 %)
31 diff
(95.5 %id)
BG747705 eye, normal pigmented retinal epithelium .a 4373 to 5268 1 to 892       892/894
(99 %)
17 diff
(98.1 %id)
T77675 whole brain .a 4381 to 4790 1 to 414       414/421
(98 %)
14 diff
(96.7 %id)
U79259 brain .a 4381 to 6064 1 to 1683   AAA Possibly primed on the genome, locally A rich (18/20 A in genome downstream of last aligned base) 1683/1683
(100 %)
2 diff
(99.9 %id)
BF087449 head_neck .a 4506 to 4871 386 to 18       369/386
(95 %)
0 diff
(100 %id)
CN306203 embryonic stem cells, cell lines H1, H7, andH9 .a 4537 to 5156 12 to 631       620/631
(98 %)
6 diff
(99.1 %id)
EL733435 mixed .a 4586 to 5231 1 to 646       646/646
(100 %)
2 diff
(99.7 %id)
TI_1948080290   .a 4586 to 5385 126 to 925       800/1333
(60 %)
15 diff
(98.9 %id)
TI_1948242384   .a 4586 to 5767 141 to 1303       1163/1386
(83 %)
67 diff
(95.2 %id)
TI_1948242385   .a 4586 to 5528 130 to 1063       934/1377
(67 %)
26 diff
(98.2 %id)
TI_1948242662   .a 4586 to 5758 137 to 1273       1137/1357
(83 %)
71 diff
(94.8 %id)
TI_1948242663   .a 4586 to 5613 131 to 1149       1019/1386
(73 %)
41 diff
(97.1 %id)
TI_1948242947   .a 4586 to 5642 123 to 1176       1054/1363
(77 %)
39 diff
(97.2 %id)
TI_1948242948   .a 4586 to 5495 130 to 1031       902/1367
(65 %)
35 diff
(97.5 %id)
TI_1948243237   .a 4586 to 5575 126 to 1117       992/1401
(70 %)
6 diff
(99.6 %id)
TI_1948243238   .a 4586 to 5564 126 to 1103       978/1431
(68 %)
32 diff
(97.8 %id)
AL110426 testis .a 4590 to 5277 1 to 690       690/695
(99 %)
7 diff
(99.0 %id)
AA176547 muscle, skeletal muscle .a 4627 to 5072 1 to 446       446/447
(99 %)
7 diff
(98.5 %id)
BG679008 skin, squamous cell carcinoma .a 4634 to 5186 1 to 544       544/544
(100 %)
16 diff
(97.1 %id)
CR998722 T-Lymphocytes .a 4677 to 5314 1 to 638       638/645
(98 %)
4 diff
(99.4 %id)
AI536586 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4714 to 4931 241 to 24       218/241
(90 %)
8 diff
(96.7 %id)
AW603503 colon_normal .a 4813 to 5074 1 to 260       260/260
(100 %)
3 diff
(98.9 %id)
AW806660 stomach .a 4844 to 5425 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BM714559 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4896 to 5536 1 to 641     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 641/641
(100 %)
1 diff
(99.9 %id)
TI_1948242664   .a 4939 to 5784 969 to 129       841/1269
(66 %)
0 diff
(100 %id)
BQ340818 nervous_normal .a 4954 to 5060 116 to 10       107/116
(92 %)
0 diff
(100 %id)
BF569850 Kidney, renal carcinoma (ascites) .a 5033 to 5830 1 to 798       798/1055
(75 %)
20 diff
(98.2 %id)
TI_1948242665   .a 5069 to 5784 837 to 122       716/1198
(59 %)
0 diff
(100 %id)
TI_1948243240   .a 5075 to 5784 839 to 124       716/1223
(58 %)
0 diff
(100 %id)
TI_1948243239   .a 5123 to 5784 788 to 127       662/1316
(50 %)
0 diff
(100 %id)
AV746511 Pituitary .a 5171 to 5647 1 to 465       465/482
(96 %)
13 diff
(97.4 %id)
TI_1948242949   .a 5184 to 5784 729 to 128       602/1320
(45 %)
0 diff
(100 %id)
TI_1948242950   .a 5187 to 5784 723 to 122       602/1217
(49 %)
0 diff
(100 %id)
BM709731 eye, Retina Foveal and Macular .a 5209 to 5734 1 to 526     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 526/529
(99 %)
2 diff
(99.7 %id)
BE546213 cervical carcinoma cell line, cervix .a 5273 to 5885 1 to 615       612/615
(99 %)
1 diff
(99.9 %id)
Z41887 brain, total brain .a 5404 to 5616 3 to 212       210/212
(99 %)
10 diff
(95.3 %id)
BG677565 skin, squamous cell carcinoma .a 5406 to 5914 9 to 511       498/726
(68 %)
11 diff
(98.5 %id)
D52823   .a 5457 to 5957 1 to 485       485/527
(92 %)
11 diff
(98.0 %id)
DB326584 brain .a 5532 to 6072 541 to 1       541/541
(100 %)
0 diff
(100 %id)
BG271510 normal head/neck tissue .a 5731 to 6077 346 to 1       346/366
(94 %)
2 diff
(99.5 %id)
BU733680 eye, Retina Foveal and Macular .a 5898 to 6072 191 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 175/181
(96 %)
0 diff
(100 %id)
BM675329 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5912 to 6254 362 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 344/344
(100 %)
2 diff
(99.5 %id)
BY800177 eye .b-u 1 to 578 1 to 578   tiling clone,   578/578
(100 %)
0 diff
(100 %id)
CA393712 eye, RPE/choroid .b-u 306 to 756 1 to 451   tiling clone,   451/451
(100 %)
0 diff
(100 %id)
N35956 melanocyte .b-u 317 to 659 1 to 342       342/347
(98 %)
13 diff
(96.3 %id)
TI_57244272   .b-u 342 to 952 220 to 835   tiling clone,   616/835
(73 %)
8 diff
(99.1 %id)
BI016117 lung_tumor .b-u 425 to 608 1 to 179       179/179
(100 %)
6 diff
(96.7 %id)
BF756768 colon .b-u 761 to 1192 466 to 21     Submitted on the opposite strand 446/466
(95 %)
25 diff
(94.7 %id)
BG950236 colon .b-u 800 to 1042 305 to 64   tiling clone,   242/306
(79 %)
0 diff
(100 %id)
CN291830 embryonic stem cells, DMSO-treated H9 cellline .b-u 866 to 1433 1 to 568   tiling clone,   568/568
(100 %)
1 diff
(99.9 %id)
AW205753   .b-u 1470 to 1828 359 to 1   tiling clone,   359/359
(100 %)
0 diff
(100 %id)
TI_153989840   .b-u 1470 to 1836 430 to 64       367/738
(49 %)
0 diff
(100 %id)
BG060017 brain, glioblastoma without EGFR amplification .b-u 1471 to 1820 350 to 1       350/350
(100 %)
0 diff
(100 %id)
BF434367 fibrotheoma, ovary .b-u 1479 to 1753 275 to 1       275/275
(100 %)
0 diff
(100 %id)
AW166358 cervix .b-u 1484 to 1829 346 to 1       346/346
(100 %)
0 diff
(100 %id)
H38425 brain .b-u 1487 to 1794 320 to 12       309/323
(95 %)
0 diff
(100 %id)
BG055913 anaplastic oligodendroglioma, brain .b-u 1491 to 1820 330 to 1       330/330
(100 %)
0 diff
(100 %id)
R87696 brain .b-u 1494 to 1774 284 to 1       284/284
(100 %)
3 diff
(99.0 %id)
CV569225 cornea, eye .b-u 1549 to 1821 1 to 273       273/273
(100 %)
0 diff
(100 %id)
AI521992 Kidney .b-u 1583 to 1753 171 to 1       171/171
(100 %)
0 diff
(100 %id)
AA411711 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b-u 1822 to 2114 1 to 283     Submitted on the opposite strand 283/283
(100 %)
11 diff
(96.2 %id)
AI440379 B-cell, chronic lymphotic leukemia .b-u 1822 to 2298 1 to 477     Submitted on the opposite strand 477/477
(100 %)
1 diff
(99.8 %id)
AI400776 B-cell, chronic lymphotic leukemia .b-u 1822 to 2204 1 to 382     Submitted on the opposite strand 382/382
(100 %)
5 diff
(98.7 %id)
AI971666 pooled germ cell tumors .b-u 1822 to 2311 1 to 490     Submitted on the opposite strand 490/490
(100 %)
0 diff
(100 %id)
AW628710 pooled .b-u 1822 to 2358 1 to 537   tiling clone, Submitted on the opposite strand 537/537
(100 %)
0 diff
(100 %id)
BX114728 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b-u 1824 to 2148 325 to 1     Submitted on the opposite strand 325/325
(100 %)
0 diff
(100 %id)
AW969173   .b-u 1829 to 2370 1 to 545       545/545
(100 %)
15 diff
(97.3 %id)
R85491 brain .b-u 1829 to 2225 1 to 407     Submitted on the opposite strand 407/409
(99 %)
9 diff
(97.8 %id)
AI933793 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b-u 1830 to 2057 1 to 228     Submitted on the opposite strand 228/228
(100 %)
0 diff
(100 %id)
AI983324 brain, three pooled meningiomas .b-u 1830 to 2138 1 to 309     Submitted on the opposite strand 309/487
(63 %)
3 diff
(99.4 %id)
AW167218 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b-u 1830 to 2289 1 to 459     Submitted on the opposite strand 459/459
(100 %)
1 diff
(99.8 %id)
R86702 brain .b-u 1875 to 2252 1 to 386     Submitted on the opposite strand 386/438
(88 %)
15 diff
(96.6 %id)
AA897790 pooled .b-u 1875 to 2018 1 to 142     Submitted on the opposite strand 142/142
(100 %)
2 diff
(98.6 %id)
AA521475 germinal center B cell .b-u 1887 to 2363 1 to 478     Submitted on the opposite strand 478/487
(98 %)
10 diff
(98.0 %id)
H28115 brain .b-u 1910 to 2203 1 to 291     Submitted on the opposite strand 291/291
(100 %)
7 diff
(97.6 %id)
TI_154162267   .b-u 1910 to 2451 184 to 729       546/730
(74 %)
51 diff
(93.1 %id)
AA406089 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b-u 1921 to 2126 205 to 1     Submitted on the opposite strand 205/205
(100 %)
5 diff
(97.6 %id)
AA027190 uterus .b-u 1951 to 2293 1 to 343     Submitted on the opposite strand 343/344
(99 %)
5 diff
(98.6 %id)
AW505562 lymph .b-u 2011 to 2254 1 to 247       247/247
(100 %)
5 diff
(98.0 %id)
R87360 brain .b-u 2323 to 2580 1 to 258   tiling clone,   258/261
(98 %)
3 diff
(98.9 %id)
BM545038 ovary (pool of 3) .c 1 to 897 19 to 926 exact tiling clone,   908/1170
(77 %)
37 diff
(96.9 %id)
BC042058 Ovary, pooled from 3 adults .c 2 to 1622 1 to 1620   tiling clone, AAA   1620/1702
(95 %)
7 diff
(99.6 %id)
AW374347 colon .d-u 1 to 161 1 to 159   tiling clone,   159/159
(100 %)
7 diff
(95.6 %id)
BQ771569 Chondrosarcoma Grade II, Left Pelvis .d-u 32 to 366 353 to 19   AAA   335/335
(100 %)
8 diff
(97.7 %id)
W81249 heart .d-u 123 to 348 26 to 252   tiling clone, fully sequenced,   227/252
(90 %)
11 diff
(95.7 %id)
BM977754 lung, Primary Lung Cystic Fibrosis EpithelialCells .d-u 143 to 374 232 to 1   tiling clone,   232/232
(100 %)
7 diff
(97.0 %id)
BU684469 lung, Primary Lung Cystic Fibrosis EpithelialCells .d-u 205 to 378 170 to 1       170/170
(100 %)
5 diff
(97.1 %id)
AW080219 esophagus, squamous cell carcinoma .d-u 227 to 371 145 to 1   tiling clone,   145/145
(100 %)
0 diff
(100 %id)
AI768755 2 pooled tumors (clear cell type), Kidney .d-u 230 to 556 332 to 6       327/332
(98 %)
0 diff
(100 %id)
AI754203 bone marrow stroma .d-u 231 to 377 146 to 1       146/146
(100 %)
2 diff
(98.7 %id)
AI017655 Kidney .d-u 231 to 363 133 to 1       133/133
(100 %)
0 diff
(100 %id)
BU429375 lymph .d-u 238 to 379 163 to 18     Submitted on the opposite strand 146/163
(89 %)
0 diff
(100 %id)
BF516035   .d-u 238 to 378 146 to 6       141/146
(96 %)
0 diff
(100 %id)
AW069028 bone marrow stroma .d-u 248 to 377 129 to 1       129/129
(100 %)
2 diff
(98.5 %id)
AA514886 colon .d-u 257 to 562 306 to 1       306/306
(100 %)
0 diff
(100 %id)
AI584108 adenocarcinoma, Pancreas .d-u 257 to 363 109 to 3       107/109
(98 %)
0 diff
(100 %id)
TI_154111458   .d-u 267 to 778 537 to 26 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 512/986
(51 %)
4 diff
(99.6 %id)
BX091228 senescent fibroblast .d-u 272 to 750 1 to 477 exact     477/477
(100 %)
2 diff
(99.6 %id)
W30745 senescent fibroblast .d-u 272 to 765 1 to 502 K3X V16G Q17A E18R V19G ... fully sequenced,   502/502
(100 %)
14 diff
(97.3 %id)
W58530 heart .d-u 291 to 756 12 to 485 V16R Q17A E18R V19G A20C ... fully sequenced,   474/485
(97 %)
11 diff
(97.8 %id)
AW268489 pooled .d-u 291 to 781 491 to 1 exact tiling clone,   491/491
(100 %)
1 diff
(99.8 %id)
BQ018703 lung, Metastatic Chondrosarcoma .d-u 294 to 774 481 to 1 exact     481/504
(95 %)
0 diff
(100 %id)
TI_154091086   .d-u 294 to 778 576 to 92 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 485/887
(54 %)
0 diff
(100 %id)
CA434311 lung, Metastatic Chondrosarcoma .d-u 294 to 774 481 to 1 exact     481/504
(95 %)
0 diff
(100 %id)
BM989685 lung, Metastatic Chondrosarcoma .d-u 315 to 778 496 to 33 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 464/482
(96 %)
0 diff
(100 %id)
W81712 heart .d-u 318 to 768 462 to 1 T2R K3X K5X R7K R11S ... fully sequenced,   462/462
(100 %)
17 diff
(96.4 %id)
BQ082075 lymph node, stomach .d-u 324 to 660 1 to 337       337/337
(100 %)
2 diff
(99.5 %id)
W58418 heart .d-u 342 to 757 417 to 1 exact fully sequenced,   417/417
(100 %)
1 diff
(99.8 %id)
AW439375 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d-u 346 to 761 417 to 1 A70V P73R A76T N77K S78F ...     417/417
(100 %)
5 diff
(98.9 %id)
AI803512   .d-u 350 to 773 424 to 1 T2P     424/424
(100 %)
1 diff
(99.8 %id)
AW474742 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d-u 350 to 779 431 to 1 exact     431/431
(100 %)
1 diff
(99.8 %id)
BM127710 Islets of Langerhans, Pancreas .d-u 353 to 786 1 to 434 T2S K4P     434/434
(100 %)
4 diff
(99.1 %id)
CK906273 Islets of Langerhans, Pancreas .d-u 353 to 736 1 to 384   AAA   384/384
(100 %)
0 diff
(100 %id)
AA927142 pooled .d-u 360 to 781 422 to 1 exact     422/422
(100 %)
0 diff
(100 %id)
AA688390 normal prostate, Prostate .d-u 369 to 767 399 to 1       399/400
(99 %)
0 diff
(100 %id)
AA856845 ovary .d-u 370 to 783 414 to 1       414/414
(100 %)
2 diff
(99.6 %id)
CA437552 lung, Metastatic Chondrosarcoma .d-u 389 to 736 364 to 19   AAA   346/353
(98 %)
2 diff
(99.5 %id)
BF435884 pooled .d-u 396 to 782 387 to 1       387/387
(100 %)
0 diff
(100 %id)
AA829078 ovary .d-u 410 to 790 400 to 20   tiling clone,   381/443
(86 %)
0 diff
(100 %id)
T60239 ovary .d-u 425 to 756 1 to 335   fully sequenced,   335/335
(100 %)
8 diff
(97.7 %id)
CK906272 Islets of Langerhans, Pancreas .d-u 429 to 782 354 to 1       354/354
(100 %)
0 diff
(100 %id)
N94466 senescent fibroblast .d-u 459 to 777 325 to 1   fully sequenced,   325/325
(100 %)
2 diff
(99.4 %id)
CB048125 Prostate .d-u 527 to 779 256 to 4       253/265
(95 %)
0 diff
(100 %id)
BE857707 Prostate .d-u 560 to 750 199 to 8       192/199
(96 %)
0 diff
(100 %id)
T60121 ovary .d-u 664 to 758 102 to 1   fully sequenced,   102/102
(100 %)
0 diff
(100 %id)
BU146979 Spleen .e 1 to 904 1 to 922   tiling clone,   922/925
(99 %)
47 diff
(95.0 %id)
CV573262 cornea, eye .e 855 to 1483 1 to 630 G114W S116F P117S G118W A119S ... tiling clone,   630/630
(100 %)
1 diff
(99.9 %id)
BU949869 Pancreas, Purified pancreatic islet .f 1 to 511 1 to 511 exact tiling clone,   511/511
(100 %)
0 diff
(100 %id)
CK902746 Pancreas, Purified pancreatic islet .f 235 to 742 508 to 1     Submitted on the opposite strand 508/508
(100 %)
2 diff
(99.7 %id)
BU949585 Pancreas, Purified pancreatic islet .f 342 to 820 479 to 1   tiling clone,   479/479
(100 %)
0 diff
(100 %id)
CN371148 embryonic stem cells, DMSO-treated H9 cellline .g 1 to 661 1 to 663 exact tiling clone,   663/663
(100 %)
4 diff
(99.4 %id)
BQ425225 eye, retinoblastoma .h 1 to 590 1 to 595 exact tiling clone, available from MGC,   595/931
(63 %)
16 diff
(98.3 %id)
BY795550 eye .h 2 to 550 1 to 549 exact tiling clone,   549/549
(100 %)
0 diff
(100 %id)
CN287818 embryonic stem cells, cell lines H1, H7, andH9 .h 566 to 1106 1 to 541   tiling clone,   541/541
(100 %)
0 diff
(100 %id)
BM692196 eye, human retina Gene AHDC1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BU728746 eye, human retina Gene AHDC1, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
BC064935 Eye, retinoblastoma Gene AHDC1, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d-u, .e, .f, .g, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI